Skip to main content

Table 7 Outcome variables by mode of CBT delivery

From: Cognitive-behavioural therapy has no effect on disease activity but improves quality of life in subgroups of patients with inflammatory bowel disease: a pilot randomised controlled trial

 

F2F

cCBT

 

Baseline

6 months

12 months

Baseline

6 months

12 months

n = 22

n = 16

n = 15

n = 68

n = 35

n = 27

 

Mean (SD)

Physical QoL

 

43.2 (11.1)

41.1 (13.4)

43.5 (12.1)

47.7 (8.4)

49.2 (7.7)

50.9 (8.4)

Mental QoL

 

42.3 (10.8)

48.1 (7.7)

43.8 (10.7)

45.5 (11.5)

48.4 (9.9)

46.4 (11.4)

HADS Anxiety

 

7.8 (3.1)

6.2 (2.0)

6.7 (2.7)

6.7 (4.2)

5.8 (3.8)

6.4 (4.8)

HADS Depression

 

5.1 (2.7)

4 (2.5)

4.7 (2.9)

4.1 (3.6)

3.3. (3.1)

3.7 (3.5)

State Anxiety

 

41.1 (12.9)

36.1 (10.8)

38.3 (10.1)

36.4 (13.1)

33.8 (11.1)

34.6 (14.5)

Trait Anxiety

 

43.3 (11.2)

36.3 (13.7)

42.2 (10.2)

38.1 (11.9)

36 (9.7)

37.9 (13.5)

Adaptive coping

Range: 20–80 (higher is better)

44.1 (10.3)

45 (13.6)

46.1 (12.5)

42.2 (13.5)

40.6 (13.6)

37.6 (12.4)

Maladaptive coping

Range: 8–32 (lower is better)

11.8 (2.7)

10.3 (1.9)

11.4 (3.4)1

10.6 (3.8)

9.5 (2.9)

10.2 (3.8)

Stress

>300 high stress 150–299 moderate stress <150 low stress

660.4 (606.1)

755.8 (934.2)

406.1 (471.6)

630.7 (689.6)

345.5 (434.7)

240.9 (241.5)2

TTM Stage

Pre-contemplation

4.6 (1.3)

3.5 (1.4)

3.3 (1.9)3

4.5 (1.7)

4.6 (2.1)

4.7 (1.8)

Range:2–10 (higher scores mean greater agreement)

 

Contemplation

7.1 (1.9)

7 (1.7)

6.8 (1.9)

6.5 (2.1)

6.5 (1.9)

6.5 (1.4)

 

Preparation

7.2 (1.9)

7.4 (2.1)

7.3 (2.1)

6 (2.3)

6.2 (2.5)

5.9 (2.4)

 

Action

6.8 (2.1)

7.3 (2.1)

7.1 (2.1)

5.4 (2.1)

5.8 (2.3)

5.5 (2.3)

 

Maintenance

7.6 (1.6)

8 (1.2)

7.5 (1.7)

6.9 (2.1)

7.6 (1.8)

7.2 (1.9)

CDAI

 

140.3 (87.1)

75.3 (83.3)

79.5 (111.6)

101.2 (65.5)

97.3 (93.7)

86.9 (88.2)

SCCAI

 

3.7 (1.1)

4.3 (1.4)

4.0 (1.1)

3.2 (1.5)

3 (1.9)

2.3 (1.5)

  1. 1A significant improvement in maladaptive coping between baseline and 12 months in the F2F group (chi2 (2) = 7.20, p = .027).
  2. 2A significant improvement in stress between baseline and 12 months in the cCBT group (chi2 (2) = 8.79, p = .012).
  3. 3A significant drop (improvement) in Precontemplation between baseline and 12 months in the F2F group (chi2 (2) = 12.3, p = .002).
Back to article page

BMC Gastroenterology

ISSN: 1471-230X

Contact us